Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Genetic Testing | 93 | 2024 | 3530 | 7.750 |
Why?
|
Genetic Variation | 86 | 2024 | 6540 | 5.480 |
Why?
|
Genome, Human | 70 | 2024 | 4416 | 5.260 |
Why?
|
Genomics | 84 | 2024 | 5790 | 4.840 |
Why?
|
Databases, Genetic | 45 | 2024 | 1739 | 4.740 |
Why?
|
Genetics, Medical | 22 | 2022 | 336 | 3.540 |
Why?
|
Information Dissemination | 22 | 2023 | 1132 | 3.320 |
Why?
|
Genetic Diseases, Inborn | 16 | 2024 | 601 | 3.310 |
Why?
|
Rare Diseases | 17 | 2024 | 619 | 3.250 |
Why?
|
Sequence Analysis, DNA | 37 | 2024 | 4717 | 2.510 |
Why?
|
High-Throughput Nucleotide Sequencing | 33 | 2024 | 3618 | 1.940 |
Why?
|
Genetic Predisposition to Disease | 52 | 2024 | 17766 | 1.920 |
Why?
|
Hearing Loss | 20 | 2022 | 780 | 1.710 |
Why?
|
Laboratories | 8 | 2024 | 461 | 1.630 |
Why?
|
Hearing Loss, Sensorineural | 14 | 2024 | 781 | 1.520 |
Why?
|
Pathology, Molecular | 5 | 2021 | 330 | 1.480 |
Why?
|
Connexins | 15 | 2019 | 351 | 1.360 |
Why?
|
Genetic Association Studies | 18 | 2024 | 2716 | 1.220 |
Why?
|
Molecular Diagnostic Techniques | 6 | 2021 | 612 | 1.080 |
Why?
|
Genetic Counseling | 13 | 2022 | 625 | 0.930 |
Why?
|
Neonatal Screening | 10 | 2023 | 595 | 0.920 |
Why?
|
Software | 23 | 2023 | 4420 | 0.910 |
Why?
|
Cardiomyopathy, Hypertrophic | 8 | 2017 | 1300 | 0.860 |
Why?
|
Phenotype | 44 | 2024 | 16543 | 0.860 |
Why?
|
Disease | 8 | 2023 | 671 | 0.840 |
Why?
|
Computational Biology | 15 | 2024 | 3504 | 0.840 |
Why?
|
Mutation | 43 | 2024 | 29950 | 0.810 |
Why?
|
Deafness | 9 | 2022 | 456 | 0.770 |
Why?
|
Humans | 259 | 2024 | 760261 | 0.720 |
Why?
|
Cardiomyopathies | 7 | 2024 | 1945 | 0.700 |
Why?
|
Oligonucleotide Array Sequence Analysis | 5 | 2015 | 3774 | 0.690 |
Why?
|
Guidelines as Topic | 5 | 2019 | 1395 | 0.680 |
Why?
|
Penetrance | 7 | 2024 | 388 | 0.670 |
Why?
|
Pharmacogenetics | 7 | 2022 | 680 | 0.640 |
Why?
|
Incidental Findings | 8 | 2018 | 698 | 0.640 |
Why?
|
Awards and Prizes | 1 | 2023 | 359 | 0.630 |
Why?
|
Alleles | 20 | 2024 | 6900 | 0.600 |
Why?
|
Gene Frequency | 16 | 2024 | 3605 | 0.600 |
Why?
|
Cardiomyopathy, Dilated | 9 | 2023 | 819 | 0.600 |
Why?
|
Heterozygote | 14 | 2024 | 2797 | 0.550 |
Why?
|
Publications | 2 | 2020 | 194 | 0.540 |
Why?
|
Clinical Laboratory Information Systems | 1 | 2017 | 108 | 0.530 |
Why?
|
Metagenomics | 1 | 2019 | 457 | 0.530 |
Why?
|
Usher Syndromes | 5 | 2018 | 54 | 0.520 |
Why?
|
Delivery of Health Care | 6 | 2023 | 5324 | 0.510 |
Why?
|
DNA Copy Number Variations | 7 | 2024 | 2008 | 0.500 |
Why?
|
Blindness | 4 | 2012 | 582 | 0.500 |
Why?
|
Terminology as Topic | 5 | 2024 | 1534 | 0.490 |
Why?
|
Professional Role | 1 | 2018 | 311 | 0.490 |
Why?
|
DNA Mutational Analysis | 12 | 2013 | 4109 | 0.480 |
Why?
|
Genes, Recessive | 9 | 2024 | 626 | 0.480 |
Why?
|
Data Interpretation, Statistical | 3 | 2019 | 2696 | 0.480 |
Why?
|
Long QT Syndrome | 4 | 2022 | 465 | 0.450 |
Why?
|
Medical Informatics | 5 | 2021 | 733 | 0.440 |
Why?
|
Information Storage and Retrieval | 1 | 2018 | 821 | 0.420 |
Why?
|
Myosins | 4 | 2021 | 405 | 0.420 |
Why?
|
Multifactorial Inheritance | 5 | 2023 | 1351 | 0.420 |
Why?
|
Duty to Recontact | 3 | 2021 | 19 | 0.410 |
Why?
|
Clinical Laboratory Techniques | 2 | 2017 | 749 | 0.410 |
Why?
|
Pedigree | 15 | 2021 | 4577 | 0.410 |
Why?
|
Ultrasonography, Prenatal | 2 | 2023 | 1745 | 0.390 |
Why?
|
Nephrotic Syndrome | 3 | 2021 | 391 | 0.380 |
Why?
|
Genome | 5 | 2022 | 1739 | 0.350 |
Why?
|
Genotype | 20 | 2024 | 12959 | 0.350 |
Why?
|
Sequence Analysis | 4 | 2020 | 240 | 0.340 |
Why?
|
Patient Selection | 2 | 2018 | 4276 | 0.330 |
Why?
|
Evidence-Based Practice | 3 | 2019 | 495 | 0.320 |
Why?
|
Spasms, Infantile | 1 | 2012 | 296 | 0.310 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2018 | 2052 | 0.310 |
Why?
|
Polymerase Chain Reaction | 6 | 2018 | 6067 | 0.300 |
Why?
|
Donor Selection | 1 | 2009 | 228 | 0.290 |
Why?
|
Access to Information | 3 | 2023 | 320 | 0.290 |
Why?
|
Carrier Proteins | 7 | 2021 | 4938 | 0.290 |
Why?
|
Antigens, Human Platelet | 2 | 2018 | 41 | 0.280 |
Why?
|
United States | 31 | 2024 | 72363 | 0.280 |
Why?
|
Age of Onset | 4 | 2024 | 3302 | 0.280 |
Why?
|
Nephrology | 2 | 2020 | 263 | 0.280 |
Why?
|
Podocytes | 3 | 2021 | 402 | 0.280 |
Why?
|
Biological Specimen Banks | 2 | 2023 | 776 | 0.270 |
Why?
|
Adenosine Monophosphate | 2 | 2019 | 283 | 0.270 |
Why?
|
Urogenital Abnormalities | 2 | 2020 | 256 | 0.270 |
Why?
|
Disclosure | 5 | 2021 | 738 | 0.270 |
Why?
|
Mutation, Missense | 6 | 2024 | 2563 | 0.270 |
Why?
|
Genetics, Population | 2 | 2023 | 929 | 0.270 |
Why?
|
Infant, Newborn | 22 | 2023 | 26168 | 0.260 |
Why?
|
Biomedical Research | 3 | 2016 | 3421 | 0.260 |
Why?
|
Chromosome Mapping | 8 | 2023 | 4625 | 0.260 |
Why?
|
Societies, Medical | 6 | 2019 | 3903 | 0.260 |
Why?
|
Human Genome Project | 4 | 2024 | 199 | 0.260 |
Why?
|
Cochlear Diseases | 1 | 2005 | 23 | 0.250 |
Why?
|
Genes, BRCA2 | 2 | 2019 | 604 | 0.250 |
Why?
|
Spermatozoa | 1 | 2009 | 631 | 0.250 |
Why?
|
Primary Health Care | 6 | 2023 | 4649 | 0.250 |
Why?
|
Kidney Diseases | 2 | 2020 | 2093 | 0.250 |
Why?
|
Membrane Proteins | 9 | 2019 | 7854 | 0.250 |
Why?
|
Genome-Wide Association Study | 11 | 2024 | 12602 | 0.250 |
Why?
|
Speech Intelligibility | 1 | 2005 | 79 | 0.250 |
Why?
|
Child | 36 | 2024 | 79758 | 0.240 |
Why?
|
Point Mutation | 1 | 2010 | 1594 | 0.240 |
Why?
|
Child, Preschool | 23 | 2024 | 42034 | 0.230 |
Why?
|
Genes, Dominant | 3 | 2016 | 863 | 0.230 |
Why?
|
RNA, Small Nuclear | 1 | 2024 | 74 | 0.230 |
Why?
|
Spliceosomes | 2 | 2024 | 129 | 0.230 |
Why?
|
Female | 73 | 2024 | 391011 | 0.230 |
Why?
|
Genetic Heterogeneity | 2 | 2019 | 724 | 0.220 |
Why?
|
Base Sequence | 10 | 2023 | 12447 | 0.220 |
Why?
|
Male | 67 | 2024 | 359413 | 0.220 |
Why?
|
Sequence Deletion | 3 | 2015 | 1493 | 0.220 |
Why?
|
Virulence | 3 | 2024 | 1295 | 0.220 |
Why?
|
Actinin | 1 | 2024 | 163 | 0.220 |
Why?
|
Infant | 22 | 2024 | 36030 | 0.220 |
Why?
|
Ryanodine Receptor Calcium Release Channel | 1 | 2024 | 182 | 0.220 |
Why?
|
Ectodermal Dysplasia | 1 | 2024 | 106 | 0.210 |
Why?
|
Developmental Disabilities | 3 | 2021 | 1504 | 0.210 |
Why?
|
Frameshift Mutation | 2 | 2024 | 388 | 0.210 |
Why?
|
Cochlea | 4 | 2011 | 843 | 0.210 |
Why?
|
Databases, Nucleic Acid | 2 | 2016 | 204 | 0.210 |
Why?
|
Research Report | 2 | 2016 | 370 | 0.200 |
Why?
|
Death, Sudden, Cardiac | 2 | 2021 | 1572 | 0.200 |
Why?
|
Shal Potassium Channels | 1 | 2021 | 20 | 0.200 |
Why?
|
Database Management Systems | 2 | 2015 | 258 | 0.200 |
Why?
|
Genome, Mitochondrial | 1 | 2022 | 66 | 0.190 |
Why?
|
Truth Disclosure | 2 | 2019 | 432 | 0.190 |
Why?
|
Nervous System Diseases | 1 | 2012 | 1647 | 0.190 |
Why?
|
Practice Guidelines as Topic | 6 | 2020 | 7468 | 0.190 |
Why?
|
Research Personnel | 2 | 2017 | 584 | 0.190 |
Why?
|
Tandem Repeat Sequences | 1 | 2022 | 181 | 0.190 |
Why?
|
Hereditary Central Nervous System Demyelinating Diseases | 1 | 2021 | 42 | 0.190 |
Why?
|
Adult | 44 | 2024 | 219847 | 0.190 |
Why?
|
Intranuclear Space | 1 | 2021 | 15 | 0.190 |
Why?
|
Inheritance Patterns | 1 | 2023 | 340 | 0.190 |
Why?
|
Algorithms | 7 | 2019 | 13967 | 0.190 |
Why?
|
Reproducibility of Results | 11 | 2021 | 20048 | 0.180 |
Why?
|
Primates | 1 | 2023 | 523 | 0.180 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2021 | 293 | 0.180 |
Why?
|
Uncertainty | 3 | 2023 | 754 | 0.180 |
Why?
|
Peptidylprolyl Isomerase | 1 | 2020 | 97 | 0.180 |
Why?
|
Endophenotypes | 1 | 2022 | 255 | 0.180 |
Why?
|
Gastritis | 1 | 2022 | 198 | 0.180 |
Why?
|
Electronic Health Records | 7 | 2023 | 4763 | 0.180 |
Why?
|
Middle East | 1 | 2020 | 230 | 0.170 |
Why?
|
Neoplasms | 5 | 2021 | 22066 | 0.170 |
Why?
|
Informed Consent | 4 | 2021 | 1007 | 0.170 |
Why?
|
Consensus | 2 | 2020 | 3106 | 0.170 |
Why?
|
Tissue Donors | 1 | 2009 | 2314 | 0.170 |
Why?
|
Tracheoesophageal Fistula | 1 | 2021 | 131 | 0.170 |
Why?
|
Anemia, Aplastic | 1 | 2022 | 228 | 0.170 |
Why?
|
Urinary Tract | 2 | 2020 | 309 | 0.170 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2022 | 243 | 0.170 |
Why?
|
North America | 1 | 2023 | 1282 | 0.170 |
Why?
|
Cadherins | 2 | 2016 | 898 | 0.170 |
Why?
|
Craniosynostoses | 1 | 2024 | 412 | 0.170 |
Why?
|
Calcium-Binding Proteins | 2 | 2019 | 1066 | 0.170 |
Why?
|
American Medical Association | 1 | 2019 | 60 | 0.170 |
Why?
|
Ion Channel Gating | 1 | 2021 | 436 | 0.170 |
Why?
|
Duty to Warn | 1 | 2019 | 30 | 0.170 |
Why?
|
Transport Vesicles | 1 | 2019 | 81 | 0.160 |
Why?
|
Preimplantation Diagnosis | 1 | 2021 | 143 | 0.160 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2021 | 436 | 0.160 |
Why?
|
Data Mining | 1 | 2024 | 553 | 0.160 |
Why?
|
Adolescent | 24 | 2024 | 87747 | 0.160 |
Why?
|
Medical History Taking | 3 | 2020 | 773 | 0.160 |
Why?
|
Gene Dosage | 5 | 2023 | 1218 | 0.160 |
Why?
|
Extracellular Matrix Proteins | 3 | 2018 | 829 | 0.160 |
Why?
|
Ear | 1 | 1999 | 172 | 0.160 |
Why?
|
Biotinidase | 1 | 2018 | 17 | 0.160 |
Why?
|
Pregnancy Trimester, First | 2 | 2023 | 909 | 0.160 |
Why?
|
Nerve Tissue Proteins | 2 | 2021 | 4409 | 0.160 |
Why?
|
Cerebellar Diseases | 1 | 2020 | 219 | 0.160 |
Why?
|
Arabs | 1 | 2020 | 187 | 0.160 |
Why?
|
rab5 GTP-Binding Proteins | 1 | 2018 | 48 | 0.160 |
Why?
|
Esophageal Atresia | 1 | 2021 | 216 | 0.160 |
Why?
|
Genetic Loci | 2 | 2019 | 2618 | 0.150 |
Why?
|
DNA | 6 | 2021 | 7236 | 0.150 |
Why?
|
Rh-Hr Blood-Group System | 1 | 2018 | 65 | 0.150 |
Why?
|
Genomic Library | 2 | 2016 | 189 | 0.150 |
Why?
|
Blood Grouping and Crossmatching | 1 | 2018 | 100 | 0.150 |
Why?
|
rab GTP-Binding Proteins | 1 | 2019 | 251 | 0.150 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 2023 | 396 | 0.150 |
Why?
|
Retinal Degeneration | 2 | 2012 | 412 | 0.150 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 2021 | 325 | 0.150 |
Why?
|
Young Adult | 16 | 2024 | 58673 | 0.140 |
Why?
|
Polymorphism, Single Nucleotide | 9 | 2023 | 15766 | 0.140 |
Why?
|
Semicircular Canals | 2 | 2016 | 203 | 0.140 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2021 | 380 | 0.140 |
Why?
|
Vesicular Transport Proteins | 1 | 2019 | 374 | 0.140 |
Why?
|
False Positive Reactions | 2 | 2016 | 956 | 0.140 |
Why?
|
Microcephaly | 1 | 2020 | 423 | 0.140 |
Why?
|
DNA, Mitochondrial | 1 | 2022 | 857 | 0.140 |
Why?
|
Blood Vessels | 1 | 2002 | 1112 | 0.130 |
Why?
|
Gene Rearrangement | 1 | 2021 | 1122 | 0.130 |
Why?
|
Homozygote | 5 | 2013 | 1786 | 0.130 |
Why?
|
Ion Channels | 3 | 2013 | 1043 | 0.130 |
Why?
|
Cohort Studies | 13 | 2024 | 41317 | 0.130 |
Why?
|
ABO Blood-Group System | 1 | 2018 | 369 | 0.130 |
Why?
|
Health | 1 | 2019 | 395 | 0.130 |
Why?
|
Cardiovascular Diseases | 7 | 2023 | 15740 | 0.130 |
Why?
|
Electrocardiography | 3 | 2022 | 6413 | 0.130 |
Why?
|
National Library of Medicine (U.S.) | 1 | 2015 | 35 | 0.130 |
Why?
|
Arrhythmogenic Right Ventricular Dysplasia | 1 | 2017 | 162 | 0.130 |
Why?
|
Epilepsy | 3 | 2021 | 3267 | 0.130 |
Why?
|
Sensitivity and Specificity | 7 | 2019 | 14656 | 0.130 |
Why?
|
Embryo, Mammalian | 1 | 2021 | 1667 | 0.130 |
Why?
|
Family | 4 | 2020 | 3189 | 0.130 |
Why?
|
Case-Control Studies | 8 | 2020 | 22041 | 0.120 |
Why?
|
Polycystic Kidney, Autosomal Dominant | 1 | 2016 | 166 | 0.120 |
Why?
|
Pancreatitis | 1 | 2022 | 1100 | 0.120 |
Why?
|
Ear Diseases | 1 | 2016 | 177 | 0.120 |
Why?
|
Genes, BRCA1 | 1 | 2018 | 769 | 0.120 |
Why?
|
Research Subjects | 2 | 2019 | 249 | 0.120 |
Why?
|
Parents | 2 | 2019 | 3547 | 0.120 |
Why?
|
Vesico-Ureteral Reflux | 1 | 2018 | 438 | 0.120 |
Why?
|
Colonic Polyps | 1 | 2019 | 550 | 0.120 |
Why?
|
Mechanotransduction, Cellular | 2 | 2013 | 530 | 0.120 |
Why?
|
Retina | 5 | 2011 | 2635 | 0.120 |
Why?
|
Blood Group Antigens | 1 | 2015 | 187 | 0.120 |
Why?
|
Syndrome | 5 | 2024 | 3278 | 0.110 |
Why?
|
Peripheral Vascular Diseases | 1 | 1997 | 515 | 0.110 |
Why?
|
Communication | 3 | 2024 | 3846 | 0.110 |
Why?
|
Models, Genetic | 1 | 2023 | 3442 | 0.110 |
Why?
|
Sample Size | 1 | 2016 | 840 | 0.110 |
Why?
|
Elapid Venoms | 2 | 1991 | 41 | 0.110 |
Why?
|
Fertilization in Vitro | 1 | 2021 | 1292 | 0.110 |
Why?
|
Audiometry, Pure-Tone | 2 | 2005 | 210 | 0.110 |
Why?
|
Carbidopa | 1 | 2012 | 30 | 0.110 |
Why?
|
Patient Access to Records | 1 | 2014 | 119 | 0.110 |
Why?
|
Forkhead Transcription Factors | 1 | 2020 | 1613 | 0.110 |
Why?
|
Societies, Scientific | 1 | 2014 | 221 | 0.110 |
Why?
|
Sarcomeres | 2 | 2012 | 367 | 0.110 |
Why?
|
Patients | 2 | 2018 | 906 | 0.100 |
Why?
|
Retinitis Pigmentosa | 2 | 2011 | 397 | 0.100 |
Why?
|
Exons | 4 | 2023 | 2391 | 0.100 |
Why?
|
Arthrogryposis | 1 | 2013 | 68 | 0.100 |
Why?
|
Outpatients | 1 | 2020 | 1606 | 0.100 |
Why?
|
Auditory Threshold | 2 | 2005 | 369 | 0.100 |
Why?
|
Databases, Factual | 5 | 2022 | 8018 | 0.100 |
Why?
|
Levodopa | 1 | 2012 | 217 | 0.100 |
Why?
|
Hearing Loss, Bilateral | 1 | 2011 | 53 | 0.100 |
Why?
|
Audiometry | 2 | 2010 | 253 | 0.100 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2022 | 1459 | 0.100 |
Why?
|
Hearing Loss, Mixed Conductive-Sensorineural | 1 | 2011 | 13 | 0.090 |
Why?
|
Mucin-1 | 1 | 2016 | 539 | 0.090 |
Why?
|
Genes, Synthetic | 1 | 2011 | 88 | 0.090 |
Why?
|
Expert Systems | 1 | 2011 | 79 | 0.090 |
Why?
|
Aged, 80 and over | 8 | 2019 | 58947 | 0.090 |
Why?
|
Peer Review, Research | 1 | 2014 | 341 | 0.090 |
Why?
|
Intellectual Property | 1 | 2010 | 31 | 0.090 |
Why?
|
Knowledge Bases | 1 | 2011 | 98 | 0.090 |
Why?
|
International Cooperation | 1 | 2017 | 1436 | 0.090 |
Why?
|
Middle Aged | 21 | 2024 | 220175 | 0.090 |
Why?
|
Insemination, Artificial, Heterologous | 1 | 2009 | 10 | 0.090 |
Why?
|
Sperm Banks | 1 | 2009 | 7 | 0.090 |
Why?
|
Validation Studies as Topic | 1 | 2010 | 163 | 0.090 |
Why?
|
Research Design | 3 | 2014 | 6181 | 0.090 |
Why?
|
Potassium Channels | 2 | 1991 | 532 | 0.090 |
Why?
|
Prenatal Diagnosis | 1 | 2017 | 1262 | 0.090 |
Why?
|
Base Composition | 1 | 2010 | 290 | 0.090 |
Why?
|
Periodicals as Topic | 1 | 2020 | 1470 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2020 | 2978 | 0.080 |
Why?
|
Vestibule, Labyrinth | 1 | 2011 | 232 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2019 | 10340 | 0.080 |
Why?
|
Cardiac Myosins | 1 | 2009 | 124 | 0.080 |
Why?
|
Cell Cycle Proteins | 1 | 2020 | 3448 | 0.080 |
Why?
|
Costs and Cost Analysis | 1 | 2015 | 1679 | 0.080 |
Why?
|
Mass Spectrometry | 1 | 2016 | 2192 | 0.080 |
Why?
|
Chronic Disease | 1 | 2024 | 9283 | 0.080 |
Why?
|
Cost-Benefit Analysis | 2 | 2021 | 5507 | 0.080 |
Why?
|
Thrombophilia | 1 | 2011 | 307 | 0.080 |
Why?
|
Genetic Research | 2 | 2021 | 172 | 0.080 |
Why?
|
Synaptic Vesicles | 2 | 1988 | 188 | 0.080 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2012 | 378 | 0.080 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1500 | 0.080 |
Why?
|
Physicians | 2 | 2017 | 4590 | 0.080 |
Why?
|
Heart Diseases | 1 | 2021 | 2809 | 0.080 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2013 | 599 | 0.080 |
Why?
|
Pilot Projects | 5 | 2020 | 8553 | 0.080 |
Why?
|
Myosin Heavy Chains | 1 | 2009 | 402 | 0.070 |
Why?
|
Prospective Studies | 6 | 2023 | 54263 | 0.070 |
Why?
|
Nucleic Acid Hybridization | 1 | 2009 | 1304 | 0.070 |
Why?
|
Drug Discovery | 1 | 2015 | 1056 | 0.070 |
Why?
|
Visual Fields | 2 | 2011 | 1054 | 0.070 |
Why?
|
Pregnancy | 5 | 2023 | 29725 | 0.070 |
Why?
|
Aged | 13 | 2019 | 168995 | 0.070 |
Why?
|
Chromosome Breakpoints | 2 | 2018 | 93 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3758 | 0.070 |
Why?
|
Receptors, Cholinergic | 2 | 1991 | 244 | 0.070 |
Why?
|
Animals | 20 | 2024 | 167940 | 0.070 |
Why?
|
Internet | 2 | 2022 | 3074 | 0.070 |
Why?
|
DNA-Binding Proteins | 2 | 2021 | 9590 | 0.070 |
Why?
|
Temporal Bone | 1 | 2011 | 683 | 0.070 |
Why?
|
X Chromosome | 2 | 2002 | 815 | 0.070 |
Why?
|
Haplotypes | 3 | 2022 | 2764 | 0.070 |
Why?
|
DNA Primers | 2 | 2014 | 2819 | 0.070 |
Why?
|
RNA, Messenger | 4 | 2018 | 12762 | 0.060 |
Why?
|
Ultrasonography | 1 | 2019 | 5960 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2024 | 5201 | 0.060 |
Why?
|
National Human Genome Research Institute (U.S.) | 2 | 2016 | 22 | 0.060 |
Why?
|
Cardiomegaly | 1 | 2008 | 593 | 0.060 |
Why?
|
Amino Acid Substitution | 2 | 2021 | 1737 | 0.060 |
Why?
|
Molecular Sequence Data | 6 | 2013 | 17628 | 0.060 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 25928 | 0.060 |
Why?
|
Fee-for-Service Plans | 1 | 2010 | 705 | 0.060 |
Why?
|
Disease Susceptibility | 2 | 2022 | 1791 | 0.060 |
Why?
|
Intracellular Membranes | 1 | 1986 | 389 | 0.060 |
Why?
|
Risk Assessment | 6 | 2018 | 24086 | 0.060 |
Why?
|
Distal Myopathies | 1 | 2024 | 18 | 0.060 |
Why?
|
RNA Splicing | 2 | 2021 | 914 | 0.060 |
Why?
|
Kidney | 4 | 2021 | 7072 | 0.060 |
Why?
|
Attitude of Health Personnel | 2 | 2015 | 3870 | 0.060 |
Why?
|
Vision Disorders | 1 | 2011 | 1084 | 0.060 |
Why?
|
Transcription Factors | 2 | 2021 | 12100 | 0.060 |
Why?
|
Population Groups | 2 | 2016 | 211 | 0.060 |
Why?
|
Research | 3 | 2018 | 1973 | 0.060 |
Why?
|
Medical Oncology | 1 | 2015 | 2321 | 0.060 |
Why?
|
Public Health | 1 | 2017 | 2655 | 0.060 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 3466 | 0.050 |
Why?
|
Intercellular Signaling Peptides and Proteins | 3 | 2018 | 1655 | 0.050 |
Why?
|
Vertebrates | 1 | 2004 | 228 | 0.050 |
Why?
|
RNA Splice Sites | 1 | 2024 | 211 | 0.050 |
Why?
|
Limb Deformities, Congenital | 1 | 2024 | 136 | 0.050 |
Why?
|
Disease Progression | 3 | 2018 | 13505 | 0.050 |
Why?
|
Hearing Disorders | 1 | 2003 | 126 | 0.050 |
Why?
|
Coronary Artery Disease | 1 | 2023 | 6661 | 0.050 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2005 | 459 | 0.050 |
Why?
|
Risk Factors | 8 | 2024 | 74269 | 0.050 |
Why?
|
Decision Support Systems, Clinical | 1 | 2012 | 1162 | 0.050 |
Why?
|
Retinal Diseases | 1 | 2008 | 702 | 0.050 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2024 | 256 | 0.050 |
Why?
|
Stria Vascularis | 1 | 2002 | 30 | 0.050 |
Why?
|
Founder Effect | 1 | 2023 | 186 | 0.050 |
Why?
|
Genetic Techniques | 1 | 2005 | 428 | 0.050 |
Why?
|
Retinal Dystrophies | 1 | 2023 | 64 | 0.050 |
Why?
|
Quality Assurance, Health Care | 1 | 2012 | 2178 | 0.050 |
Why?
|
Healthcare Disparities | 1 | 2018 | 3381 | 0.050 |
Why?
|
RNA, Small Interfering | 3 | 2019 | 3443 | 0.050 |
Why?
|
Vestibular Function Tests | 1 | 2002 | 128 | 0.050 |
Why?
|
Acetonitriles | 1 | 2022 | 54 | 0.050 |
Why?
|
Gene Expression Regulation | 2 | 2018 | 11902 | 0.050 |
Why?
|
Prevalence | 4 | 2023 | 15687 | 0.050 |
Why?
|
Hemizygote | 1 | 2021 | 28 | 0.050 |
Why?
|
Fragile X Mental Retardation Protein | 1 | 2022 | 116 | 0.050 |
Why?
|
Hair Cells, Auditory | 1 | 2004 | 379 | 0.050 |
Why?
|
Mice | 8 | 2024 | 81216 | 0.050 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2 | 2017 | 225 | 0.050 |
Why?
|
Finland | 1 | 2023 | 602 | 0.050 |
Why?
|
Asymptomatic Diseases | 2 | 2017 | 582 | 0.050 |
Why?
|
Chromosomes, Human | 1 | 2003 | 442 | 0.050 |
Why?
|
Health Level Seven | 1 | 2021 | 35 | 0.050 |
Why?
|
Workflow | 2 | 2016 | 851 | 0.050 |
Why?
|
Heredodegenerative Disorders, Nervous System | 1 | 2020 | 16 | 0.050 |
Why?
|
Laboratory Proficiency Testing | 1 | 2020 | 20 | 0.050 |
Why?
|
Germ-Line Mutation | 2 | 2022 | 1843 | 0.050 |
Why?
|
Genes, X-Linked | 1 | 2021 | 128 | 0.050 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 1 | 2002 | 253 | 0.050 |
Why?
|
HEK293 Cells | 2 | 2020 | 4264 | 0.050 |
Why?
|
Amphibian Proteins | 1 | 2020 | 36 | 0.050 |
Why?
|
Hearing | 1 | 2004 | 501 | 0.040 |
Why?
|
Health Care Costs | 3 | 2018 | 3257 | 0.040 |
Why?
|
STAT1 Transcription Factor | 1 | 2022 | 333 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2005 | 1723 | 0.040 |
Why?
|
Molecular Sequence Annotation | 1 | 2023 | 525 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5396 | 0.040 |
Why?
|
Receptors, Interleukin | 1 | 2021 | 243 | 0.040 |
Why?
|
Xenopus | 2 | 2020 | 717 | 0.040 |
Why?
|
Computer-Assisted Instruction | 1 | 2003 | 362 | 0.040 |
Why?
|
Drosophila melanogaster | 2 | 2019 | 1711 | 0.040 |
Why?
|
Codon, Nonsense | 1 | 2021 | 282 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 6855 | 0.040 |
Why?
|
Data Collection | 2 | 2023 | 3317 | 0.040 |
Why?
|
Neuropsychological Tests | 1 | 2012 | 7016 | 0.040 |
Why?
|
Receptors, Nicotinic | 1 | 1982 | 494 | 0.040 |
Why?
|
Jews | 1 | 2021 | 364 | 0.040 |
Why?
|
Selection, Genetic | 1 | 2023 | 872 | 0.040 |
Why?
|
Ribonuclease III | 1 | 2021 | 279 | 0.040 |
Why?
|
Open Reading Frames | 1 | 2022 | 814 | 0.040 |
Why?
|
Canada | 2 | 2019 | 2128 | 0.040 |
Why?
|
Reproduction | 1 | 2023 | 647 | 0.040 |
Why?
|
Larva | 1 | 2020 | 509 | 0.040 |
Why?
|
Eye Proteins | 1 | 2002 | 633 | 0.040 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2021 | 423 | 0.040 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2022 | 789 | 0.040 |
Why?
|
Linkage Disequilibrium | 2 | 2013 | 1996 | 0.040 |
Why?
|
Cell Line, Transformed | 1 | 2019 | 871 | 0.040 |
Why?
|
Cell Line | 4 | 2021 | 15626 | 0.040 |
Why?
|
Exocytosis | 1 | 2019 | 322 | 0.040 |
Why?
|
Zebrafish Proteins | 1 | 2004 | 1006 | 0.040 |
Why?
|
Protein Subunits | 1 | 2021 | 943 | 0.040 |
Why?
|
DEAD-box RNA Helicases | 1 | 2021 | 383 | 0.040 |
Why?
|
Visual Field Tests | 2 | 2011 | 411 | 0.040 |
Why?
|
Chromatography, Ion Exchange | 2 | 1989 | 297 | 0.040 |
Why?
|
Acoustic Stimulation | 1 | 2002 | 1232 | 0.040 |
Why?
|
Erythrocytes | 2 | 2018 | 2415 | 0.040 |
Why?
|
Ethics, Research | 1 | 2019 | 178 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2020 | 803 | 0.040 |
Why?
|
Licensure | 1 | 2018 | 127 | 0.040 |
Why?
|
Protein Structure, Secondary | 1 | 2020 | 1230 | 0.040 |
Why?
|
Liability, Legal | 1 | 2019 | 210 | 0.040 |
Why?
|
Phosphate-Binding Proteins | 1 | 2018 | 93 | 0.040 |
Why?
|
Genes | 2 | 2014 | 1845 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15273 | 0.040 |
Why?
|
Saudi Arabia | 1 | 2017 | 209 | 0.040 |
Why?
|
Genetic Markers | 1 | 2003 | 2608 | 0.040 |
Why?
|
Costa Rica | 1 | 1997 | 177 | 0.030 |
Why?
|
Gene Deletion | 2 | 2015 | 2668 | 0.030 |
Why?
|
Genomic Structural Variation | 1 | 2017 | 63 | 0.030 |
Why?
|
Infertility, Female | 1 | 2023 | 760 | 0.030 |
Why?
|
Cataract | 1 | 2023 | 828 | 0.030 |
Why?
|
Gene Duplication | 1 | 2017 | 314 | 0.030 |
Why?
|
Personal Autonomy | 1 | 2019 | 302 | 0.030 |
Why?
|
Immunoglobulins | 1 | 2019 | 863 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2024 | 3601 | 0.030 |
Why?
|
Borrelia burgdorferi Group | 1 | 1996 | 97 | 0.030 |
Why?
|
Information Services | 1 | 2017 | 235 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2011 | 5793 | 0.030 |
Why?
|
Bone Marrow Transplantation | 1 | 2024 | 2696 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2020 | 14396 | 0.030 |
Why?
|
Protein Interaction Mapping | 1 | 2019 | 617 | 0.030 |
Why?
|
Patient Preference | 2 | 2013 | 921 | 0.030 |
Why?
|
Intention | 1 | 2018 | 337 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2021 | 1344 | 0.030 |
Why?
|
Models, Anatomic | 1 | 1999 | 682 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2023 | 2325 | 0.030 |
Why?
|
Pyrroles | 1 | 2022 | 1137 | 0.030 |
Why?
|
Introns | 1 | 2018 | 978 | 0.030 |
Why?
|
Australia | 1 | 2019 | 1288 | 0.030 |
Why?
|
Probability | 1 | 2020 | 2476 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2019 | 787 | 0.030 |
Why?
|
Breast Neoplasms | 3 | 2019 | 21065 | 0.030 |
Why?
|
Karyotyping | 1 | 1997 | 1172 | 0.030 |
Why?
|
Dogs | 1 | 2019 | 3843 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2021 | 1828 | 0.030 |
Why?
|
Family Health | 1 | 1999 | 1258 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 4573 | 0.030 |
Why?
|
Vinculin | 1 | 2014 | 59 | 0.030 |
Why?
|
Ambulatory Care Facilities | 1 | 2020 | 926 | 0.030 |
Why?
|
Fluorescent Dyes | 1 | 2002 | 1914 | 0.030 |
Why?
|
Amino Acid Sequence | 4 | 2020 | 13456 | 0.030 |
Why?
|
United Arab Emirates | 1 | 2013 | 48 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2019 | 1833 | 0.030 |
Why?
|
Desmoplakins | 1 | 2014 | 62 | 0.030 |
Why?
|
Genetic Privacy | 1 | 2014 | 60 | 0.030 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 1996 | 397 | 0.030 |
Why?
|
Mass Screening | 2 | 2021 | 5422 | 0.030 |
Why?
|
Referral and Consultation | 2 | 2017 | 3598 | 0.030 |
Why?
|
Protein Structure, Tertiary | 1 | 2020 | 3800 | 0.030 |
Why?
|
Educational Status | 1 | 2021 | 2512 | 0.030 |
Why?
|
Connective Tissue Diseases | 1 | 2016 | 286 | 0.030 |
Why?
|
Myopathies, Structural, Congenital | 1 | 2014 | 103 | 0.030 |
Why?
|
Sex Distribution | 1 | 2018 | 2295 | 0.030 |
Why?
|
Gene Silencing | 1 | 2019 | 1511 | 0.030 |
Why?
|
Lod Score | 1 | 2013 | 602 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2022 | 2909 | 0.030 |
Why?
|
Qualitative Research | 1 | 2023 | 2958 | 0.030 |
Why?
|
Synaptophysin | 3 | 1988 | 139 | 0.030 |
Why?
|
Models, Biological | 1 | 2009 | 9468 | 0.030 |
Why?
|
Financing, Organized | 1 | 2014 | 204 | 0.030 |
Why?
|
Viral Load | 1 | 2021 | 3323 | 0.030 |
Why?
|
Heat-Shock Proteins | 1 | 1996 | 795 | 0.030 |
Why?
|
Europe | 1 | 2019 | 3433 | 0.030 |
Why?
|
Needs Assessment | 1 | 2018 | 1137 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2021 | 2414 | 0.020 |
Why?
|
Electronic Mail | 1 | 2013 | 207 | 0.020 |
Why?
|
Ovarian Neoplasms | 2 | 2019 | 4875 | 0.020 |
Why?
|
Decision Trees | 1 | 2013 | 506 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2018 | 3967 | 0.020 |
Why?
|
Consanguinity | 1 | 2013 | 456 | 0.020 |
Why?
|
Autophagy | 1 | 2019 | 1336 | 0.020 |
Why?
|
Inservice Training | 1 | 2014 | 376 | 0.020 |
Why?
|
Codon | 1 | 2013 | 602 | 0.020 |
Why?
|
Acute Disease | 1 | 2022 | 7268 | 0.020 |
Why?
|
Pyrazoles | 1 | 2022 | 1992 | 0.020 |
Why?
|
Genetic Linkage | 1 | 1997 | 2381 | 0.020 |
Why?
|
Mutagenesis, Insertional | 1 | 2013 | 652 | 0.020 |
Why?
|
RNA Interference | 1 | 2019 | 2846 | 0.020 |
Why?
|
Petrous Bone | 1 | 2011 | 84 | 0.020 |
Why?
|
Reimbursement Mechanisms | 1 | 2016 | 664 | 0.020 |
Why?
|
Dark Adaptation | 1 | 2011 | 221 | 0.020 |
Why?
|
Prognosis | 3 | 2018 | 29636 | 0.020 |
Why?
|
Cardiomyopathy, Hypertrophic, Familial | 1 | 2010 | 63 | 0.020 |
Why?
|
Peptides | 1 | 1982 | 4358 | 0.020 |
Why?
|
Drosophila Proteins | 1 | 2019 | 1699 | 0.020 |
Why?
|
Photoreceptor Cells, Vertebrate | 1 | 2011 | 203 | 0.020 |
Why?
|
Silver Proteins | 1 | 1989 | 1 | 0.020 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2017 | 833 | 0.020 |
Why?
|
Neurotoxins | 1 | 1991 | 240 | 0.020 |
Why?
|
Electroretinography | 1 | 2011 | 518 | 0.020 |
Why?
|
Internationality | 1 | 2015 | 1005 | 0.020 |
Why?
|
Pyrimidines | 1 | 2022 | 3011 | 0.020 |
Why?
|
Cochlear Nerve | 1 | 2011 | 202 | 0.020 |
Why?
|
Escherichia coli Proteins | 1 | 1996 | 1066 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 934 | 0.020 |
Why?
|
Antibodies | 2 | 2004 | 2424 | 0.020 |
Why?
|
User-Computer Interface | 1 | 2015 | 1402 | 0.020 |
Why?
|
Filtration | 1 | 2009 | 229 | 0.020 |
Why?
|
Education, Medical, Continuing | 1 | 2014 | 830 | 0.020 |
Why?
|
Mitochondria | 1 | 2022 | 3598 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2013 | 13249 | 0.020 |
Why?
|
Health Services Research | 1 | 2016 | 1811 | 0.020 |
Why?
|
Protein Binding | 1 | 2020 | 9336 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2020 | 9531 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4554 | 0.020 |
Why?
|
Physicians, Primary Care | 1 | 2015 | 624 | 0.020 |
Why?
|
Reference Standards | 1 | 2011 | 1004 | 0.020 |
Why?
|
Computer Simulation | 1 | 2021 | 6210 | 0.020 |
Why?
|
Point-of-Care Systems | 1 | 2016 | 1208 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2013 | 2500 | 0.020 |
Why?
|
Blood Platelets | 1 | 2018 | 2522 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2011 | 2178 | 0.020 |
Why?
|
Tomography, Optical Coherence | 2 | 2011 | 2878 | 0.020 |
Why?
|
Models, Cardiovascular | 1 | 2012 | 974 | 0.020 |
Why?
|
Cattle | 2 | 1991 | 3847 | 0.020 |
Why?
|
Population Surveillance | 1 | 2017 | 2609 | 0.020 |
Why?
|
Heart Defects, Congenital | 2 | 2014 | 4668 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1989 | 1746 | 0.020 |
Why?
|
Publishing | 1 | 2014 | 837 | 0.020 |
Why?
|
Drug Combinations | 1 | 2012 | 2024 | 0.020 |
Why?
|
Cardiology | 1 | 2018 | 1723 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2021 | 3215 | 0.020 |
Why?
|
Octoxynol | 1 | 1986 | 77 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2016 | 14482 | 0.020 |
Why?
|
Patient Participation | 1 | 2015 | 1437 | 0.020 |
Why?
|
Cell Movement | 1 | 2018 | 5206 | 0.020 |
Why?
|
Vertigo | 1 | 2007 | 202 | 0.020 |
Why?
|
Health Behavior | 1 | 2017 | 2621 | 0.020 |
Why?
|
Detergents | 1 | 1986 | 235 | 0.020 |
Why?
|
Chromatography, Gel | 1 | 1986 | 645 | 0.020 |
Why?
|
Rana catesbeiana | 1 | 2004 | 85 | 0.020 |
Why?
|
Species Specificity | 1 | 1989 | 2413 | 0.020 |
Why?
|
Chromatography, Affinity | 1 | 1986 | 534 | 0.020 |
Why?
|
Registries | 1 | 2021 | 8449 | 0.020 |
Why?
|
Staining and Labeling | 1 | 1989 | 1090 | 0.020 |
Why?
|
Health Personnel | 1 | 2018 | 3310 | 0.020 |
Why?
|
Rats, Inbred Strains | 1 | 1986 | 2094 | 0.010 |
Why?
|
Health Status Disparities | 1 | 2016 | 1819 | 0.010 |
Why?
|
Decision Making | 1 | 2018 | 3924 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2011 | 2363 | 0.010 |
Why?
|
Solubility | 1 | 1986 | 1088 | 0.010 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2018 | 2296 | 0.010 |
Why?
|
Transient Receptor Potential Channels | 1 | 2004 | 130 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2017 | 3159 | 0.010 |
Why?
|
Neurons | 1 | 1982 | 9416 | 0.010 |
Why?
|
Rats | 3 | 1989 | 23695 | 0.010 |
Why?
|
Bungarotoxins | 1 | 1982 | 46 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2002 | 18134 | 0.010 |
Why?
|
Synaptic Membranes | 1 | 1982 | 89 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 1996 | 3822 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9712 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2018 | 18968 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 22025 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1987 | 4172 | 0.010 |
Why?
|
Drosophila | 1 | 1989 | 1492 | 0.010 |
Why?
|
Blotting, Western | 1 | 1989 | 5039 | 0.010 |
Why?
|
Oligonucleotides | 1 | 2004 | 588 | 0.010 |
Why?
|
Brain | 2 | 2024 | 26912 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2016 | 20484 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2004 | 1900 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2014 | 3242 | 0.010 |
Why?
|
Chick Embryo | 1 | 1982 | 981 | 0.010 |
Why?
|
Ear, Inner | 1 | 2004 | 424 | 0.010 |
Why?
|
Chickens | 1 | 1982 | 859 | 0.010 |
Why?
|
Adenoviridae | 1 | 2004 | 1084 | 0.010 |
Why?
|
Curriculum | 1 | 2014 | 3722 | 0.010 |
Why?
|
Polyethylene Glycols | 1 | 1986 | 1188 | 0.010 |
Why?
|
Molecular Weight | 2 | 1996 | 2186 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 8058 | 0.010 |
Why?
|
Incidence | 1 | 2018 | 21378 | 0.010 |
Why?
|
Glycoproteins | 1 | 1987 | 2208 | 0.010 |
Why?
|
Visual Acuity | 1 | 2008 | 2635 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2004 | 2671 | 0.010 |
Why?
|
Quantitative Trait Loci | 1 | 2007 | 2101 | 0.010 |
Why?
|
Clinical Competence | 1 | 2014 | 4786 | 0.010 |
Why?
|
Protein Conformation | 1 | 1986 | 3969 | 0.010 |
Why?
|
Laminin | 1 | 1998 | 405 | 0.010 |
Why?
|
Spheroplasts | 1 | 1996 | 6 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2016 | 36247 | 0.010 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 1996 | 283 | 0.010 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 1998 | 635 | 0.010 |
Why?
|
Teaching | 1 | 2003 | 1167 | 0.010 |
Why?
|
Linear Models | 1 | 2005 | 5876 | 0.010 |
Why?
|
Epidermal Growth Factor | 1 | 1998 | 695 | 0.010 |
Why?
|
Glycosylation | 1 | 1998 | 1097 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2016 | 39254 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2005 | 2874 | 0.010 |
Why?
|
Fibronectins | 1 | 1998 | 721 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 1987 | 7593 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2016 | 80301 | 0.010 |
Why?
|
Zebrafish | 1 | 2004 | 2996 | 0.010 |
Why?
|
Genes, Bacterial | 1 | 1996 | 1070 | 0.010 |
Why?
|
Cell Adhesion Molecules | 1 | 1998 | 1602 | 0.010 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2007 | 3695 | 0.010 |
Why?
|
Time Factors | 1 | 2013 | 40133 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 1998 | 6131 | 0.010 |
Why?
|
Antigens, Bacterial | 1 | 1996 | 1155 | 0.010 |
Why?
|
Epitopes | 1 | 1996 | 2506 | 0.010 |
Why?
|
Hot Temperature | 1 | 1996 | 1435 | 0.010 |
Why?
|
Proteolipids | 1 | 1988 | 113 | 0.000 |
Why?
|
Kinetics | 1 | 1996 | 6378 | 0.000 |
Why?
|
Electrophysiology | 1 | 1991 | 1265 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 2005 | 15827 | 0.000 |
Why?
|
Immunoblotting | 1 | 1991 | 1649 | 0.000 |
Why?
|
Macromolecular Substances | 1 | 1988 | 1433 | 0.000 |
Why?
|
Membrane Potentials | 1 | 1988 | 1095 | 0.000 |
Why?
|
Gene Expression | 1 | 1998 | 7592 | 0.000 |
Why?
|
Microscopy, Electron | 1 | 1988 | 2558 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 1996 | 9196 | 0.000 |
Why?
|